FMR CORP 13D and 13G filings for Pliant Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-07 10:01 am Sale |
2025-02-28 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 131,993 0.200% |
-3,831,424 (-96.67%) |
Filing |
| 2024-02-09 09:28 am Sale |
2024-02-08 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 3,963,417 6.617% |
-429,814 (-9.78%) |
Filing |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 4,393,231 9.010% |
-1,752,187 (-28.51%) |
Filing |
| 2022-08-10 08:10 am Purchase |
2022-08-09 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 6,145,418 12.644% |
2,672,847 (+76.97%) |
Filing |
| 2022-06-10 11:04 am Sale |
2022-06-09 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 3,472,571 9.600% |
-1,933,278 (-35.76%) |
Filing |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 5,405,849 14.999% |
83,693 (+1.57%) |
Filing |
| 2021-02-08 10:29 am Sale |
2021-02-05 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 5,322,156 15.000% |
-10,545 (-0.20%) |
Filing |
| 2020-07-10 11:38 am Purchase |
2020-07-09 | 13G | Pliant Therapeutics, Inc. PLRX |
FMR CORP | 5,332,701 14.999% |
5,332,701 (New Position) |
Filing |